ghk-cu peptide interactions with growth hormone releasing peptides Copper Honored to share our latest

(PubMed) Spence JD, Yi Q, Hankey GJ

In short, liraglutide, GLP-1 receptor agonist, has a direct effect on atherosclerosis lesion formation via promoting pro-resolving M2 macrophages phenotype

Potential theoretical advantages include: Multi-pathway appetite suppression combining amylin and incretin signals Enhanced metabolic flexibility through glucagon receptor activation (retatrutide) and amylin-mediated effects (cagrilintide) Complementary gastric emptying effects from both compounds Broader receptor coverage addressing multiple aspects of energy homeostasis However, it's critical to emphasize: no published clinical trials have evaluated the cagrilintide dosage with retatrutide combination as of 2026

10.1016/j.neubiorev.2019.06.007 Neurosci

We have found that IGF-1R, but not IR, expression is increased following CD4 + T cell activation or following differentiation toward Th17 cells